RecallDepth
Class II Ongoing

Decitabine for Injection 50mg per vial, For intravenous infusion only Cytotoxic Agent, Sterile, Rx Only, Single-Dose Vial, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 47335-361-40.

This recall is currently active, issued July 10, 2024. It was issued by Sun Pharmaceutical Industries Inc.

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
July 2, 2024
Posted
July 10, 2024
Recall Number
D-0582-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2088 vials
Firm Location
Princeton, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Out of Specification for Total Aerobic Microbial Count (TAMC) test for unfiltered bulk for decitabine for injection.

Distribution

Nationwide in the USA

Lot / Code Info

HAD2964A, Exp 7/31/2024

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class II Drug recalls